Salarius Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)13holders
1famous investor
$0.53avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Salarius Pharmaceuticals Inc. in their 13F filings. The largest holders were Armistice Capital, LLC ($44K), Horizon Kinetics Asset Management LLC ($16K) and Renaissance Technologies ($15K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Salarius Pharmaceuticals Inc.
- CUSIP
- 79400X305
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $44K |
Ownership 13 holders
| Armistice Capital, LLC | 0.00% | Reduce -4.5% | 84,000 | $44K |
| Horizon Kinetics Asset Management LLC | 0.00% | No change | 31,094 | $16K |
| Renaissance Technologies | 0.00% | Add +6.8% | 28,242 | $15K |
| Geode Capital Management, LLC | 0.00% | No change | 24,771 | $13K |
| Vanguard Group Inc. | 0.00% | No change | 14,563 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +3.0% | 8,422 | $4K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,387 | $733 |
| Morgan Stanley | 0.00% | No change | 60 | $32 |
| Wells Fargo & Company | 0.00% | Add +3.3% | 31 | $16 |
| UBS Group AG | 0.00% | Reduce -76.9% | 18 | $10 |
| Bank of America Corp. | 0.00% | No change | 16 | $8 |
| BlackRock Inc. | 0.00% | Reduce -68.1% | 15 | $8 |
| FMR LLC | 0.00% | Reduce -78.8% | 7 | $4 |
"% of holder's portfolio" is SALARIUS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Salarius Pharmaceuticals Inc. the manager owns.